Filing Details
- Accession Number:
- 0001437749-25-022549
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-10 20:52:14
- Reporting Period:
- 2025-07-08
- Filing Date:
- 2025-07-10
- Accepted Time:
- 2025-07-10 20:52:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1401667 | Puma Biotechnology Inc. | PBYI | Pharmaceutical Preparations (2834) | 770683487 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1727172 | M Douglas Hunt | C/O Puma Biotechnology, Inc. 10880 Wilshire Blvd., Suite 2150 Los Angeles CA 90024 | See Remarks | No | Yes | No | No |
Transaction Summary
Sold: | 7,817 shares | Avg. Price: $3.53 | Total Value: $27,624.35 |
Number of Shares After Transactions: | 164,894 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-07-08 | 4,374 | $3.53 | 168,337 | No | 4 | S | Direct | |
Common Stock | Disposition | 2025-07-09 | 3,443 | $3.54 | 164,894 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Adoption date of referenced 10b5-1(c) plan is: 12-14-2020